StreetInsider.com News Articles

PHARMANUTRA S.P.A.: SUCROSOMIAL IRON® MENTIONED IN THE GUIDELINES OF THE "WORLD HEALTH ORGANISATION"

Tue, 25 Mar 2025 09:00:00 -0400

THE GROUP'S PATENTED AND DESIGNED SOLUTION INDICATED AS THE ONLY ORAL IRON FOR ANAEMIA IN PEOPLE WITH CARDIOVASCULAR DISEASE AND DIABETES

PISA, Italy, March 25, 2025 /PRNewswire/ -- PharmaNutra S.p.A. (MTA:PHN), a company specializing in the field of iron and mineral nutritional supplements and medical devices for muscles and joints, announces that oral Sucrosomial® Iron, the innovative formulation designed and patented by PharmaNutra that forms the basis of SiderAL® products, has been included in the recent World Health Organisation (WHO) Guidelines entitled 'Guidance on implementing patient

PHARMANUTRA S.P.A.: SUCROSOMIAL IRON® MENTIONED IN THE GUIDELINES OF THE "WORLD HEALTH ORGANISATION"

Tue, 25 Mar 2025 09:00:00 -0400

THE GROUP'S PATENTED AND DESIGNED SOLUTION INDICATED AS THE ONLY ORAL IRON FOR ANAEMIA IN PEOPLE WITH CARDIOVASCULAR DISEASE AND DIABETES

PISA, Italy, March 25, 2025 /PRNewswire/ -- PharmaNutra S.p.A. (MTA:PHN), a company specializing in the field of iron and mineral nutritional supplements and medical devices for muscles and joints, announces that oral Sucrosomial® Iron, the innovative formulation designed and patented by PharmaNutra that forms the basis of SiderAL® products, has been included in the recent World Health Organisation (WHO) Guidelines entitled 'Guidance on implementing patient

PHARMANUTRA S.P.A.: SUCROSOMIAL IRON® MENTIONED IN THE GUIDELINES OF THE "WORLD HEALTH ORGANISATION"

Tue, 25 Mar 2025 09:00:00 -0400

THE GROUP'S PATENTED AND DESIGNED SOLUTION INDICATED AS THE ONLY ORAL IRON FOR ANAEMIA IN PEOPLE WITH CARDIOVASCULAR DISEASE AND DIABETES

PISA, Italy, March 25, 2025 /PRNewswire/ -- PharmaNutra S.p.A. (MTA:PHN), a company specializing in the field of iron and mineral nutritional supplements and medical devices for muscles and joints, announces that oral Sucrosomial® Iron, the innovative formulation designed and patented by PharmaNutra that forms the basis of SiderAL® products, has been included in the recent World Health Organisation (WHO) Guidelines entitled 'Guidance on implementing patient

PHARMANUTRA S.P.A.: SUCROSOMIAL IRON® MENTIONED IN THE GUIDELINES OF THE "WORLD HEALTH ORGANISATION"

Tue, 25 Mar 2025 09:00:00 -0400

THE GROUP'S PATENTED AND DESIGNED SOLUTION INDICATED AS THE ONLY ORAL IRON FOR ANAEMIA IN PEOPLE WITH CARDIOVASCULAR DISEASE AND DIABETES

PISA, Italy, March 25, 2025 /PRNewswire/ -- PharmaNutra S.p.A. (MTA:PHN), a company specializing in the field of iron and mineral nutritional supplements and medical devices for muscles and joints, announces that oral Sucrosomial® Iron, the innovative formulation designed and patented by PharmaNutra that forms the basis of SiderAL® products, has been included in the recent World Health Organisation (WHO) Guidelines entitled 'Guidance on implementing patient

PHARMANUTRA S.P.A.: SUCROSOMIAL IRON® MENTIONED IN THE GUIDELINES OF THE "WORLD HEALTH ORGANISATION"

Tue, 25 Mar 2025 09:00:00 -0400

THE GROUP'S PATENTED AND DESIGNED SOLUTION INDICATED AS THE ONLY ORAL IRON FOR ANAEMIA IN PEOPLE WITH CARDIOVASCULAR DISEASE AND DIABETES

PISA, Italy, March 25, 2025 /PRNewswire/ -- PharmaNutra S.p.A. (MTA:PHN), a company specializing in the field of iron and mineral nutritional supplements and medical devices for muscles and joints, announces that oral Sucrosomial® Iron, the innovative formulation designed and patented by PharmaNutra that forms the basis of SiderAL® products, has been included in the recent World Health Organisation (WHO) Guidelines entitled 'Guidance on implementing patient

PHARMANUTRA S.P.A.: SUCROSOMIAL IRON® MENTIONED IN THE GUIDELINES OF THE "WORLD HEALTH ORGANISATION"

Tue, 25 Mar 2025 09:00:00 -0400

THE GROUP'S PATENTED AND DESIGNED SOLUTION INDICATED AS THE ONLY ORAL IRON FOR ANAEMIA IN PEOPLE WITH CARDIOVASCULAR DISEASE AND DIABETES

PISA, Italy, March 25, 2025 /PRNewswire/ -- PharmaNutra S.p.A. (MTA:PHN), a company specializing in the field of iron and mineral nutritional supplements and medical devices for muscles and joints, announces that oral Sucrosomial® Iron, the innovative formulation designed and patented by PharmaNutra that forms the basis of SiderAL® products, has been included in the recent World Health Organisation (WHO) Guidelines entitled 'Guidance on implementing patient

PHARMANUTRA S.P.A.: SUCROSOMIAL IRON® MENTIONED IN THE GUIDELINES OF THE "WORLD HEALTH ORGANISATION"

Tue, 25 Mar 2025 09:00:00 -0400

THE GROUP'S PATENTED AND DESIGNED SOLUTION INDICATED AS THE ONLY ORAL IRON FOR ANAEMIA IN PEOPLE WITH CARDIOVASCULAR DISEASE AND DIABETES

PISA, Italy, March 25, 2025 /PRNewswire/ -- PharmaNutra S.p.A. (MTA:PHN), a company specializing in the field of iron and mineral nutritional supplements and medical devices for muscles and joints, announces that oral Sucrosomial® Iron, the innovative formulation designed and patented by PharmaNutra that forms the basis of SiderAL® products, has been included in the recent World Health Organisation (WHO) Guidelines entitled 'Guidance on implementing patient

PHARMANUTRA S.P.A.: SUCROSOMIAL IRON® MENTIONED IN THE GUIDELINES OF THE "WORLD HEALTH ORGANISATION"

Tue, 25 Mar 2025 09:00:00 -0400

THE GROUP'S PATENTED AND DESIGNED SOLUTION INDICATED AS THE ONLY ORAL IRON FOR ANAEMIA IN PEOPLE WITH CARDIOVASCULAR DISEASE AND DIABETES

PISA, Italy, March 25, 2025 /PRNewswire/ -- PharmaNutra S.p.A. (MTA:PHN), a company specializing in the field of iron and mineral nutritional supplements and medical devices for muscles and joints, announces that oral Sucrosomial® Iron, the innovative formulation designed and patented by PharmaNutra that forms the basis of SiderAL® products, has been included in the recent World Health Organisation (WHO) Guidelines entitled 'Guidance on implementing patient

PHARMANUTRA S.P.A.: SUCROSOMIAL IRON® MENTIONED IN THE GUIDELINES OF THE "WORLD HEALTH ORGANISATION"

Tue, 25 Mar 2025 09:00:00 -0400

THE GROUP'S PATENTED AND DESIGNED SOLUTION INDICATED AS THE ONLY ORAL IRON FOR ANAEMIA IN PEOPLE WITH CARDIOVASCULAR DISEASE AND DIABETES

PISA, Italy, March 25, 2025 /PRNewswire/ -- PharmaNutra S.p.A. (MTA:PHN), a company specializing in the field of iron and mineral nutritional supplements and medical devices for muscles and joints, announces that oral Sucrosomial® Iron, the innovative formulation designed and patented by PharmaNutra that forms the basis of SiderAL® products, has been included in the recent World Health Organisation (WHO) Guidelines entitled 'Guidance on implementing patient

PHARMANUTRA S.P.A.: SUCROSOMIAL IRON® MENTIONED IN THE GUIDELINES OF THE "WORLD HEALTH ORGANISATION"

Tue, 25 Mar 2025 09:00:00 -0400

THE GROUP'S PATENTED AND DESIGNED SOLUTION INDICATED AS THE ONLY ORAL IRON FOR ANAEMIA IN PEOPLE WITH CARDIOVASCULAR DISEASE AND DIABETES

PISA, Italy, March 25, 2025 /PRNewswire/ -- PharmaNutra S.p.A. (MTA:PHN), a company specializing in the field of iron and mineral nutritional supplements and medical devices for muscles and joints, announces that oral Sucrosomial® Iron, the innovative formulation designed and patented by PharmaNutra that forms the basis of SiderAL® products, has been included in the recent World Health Organisation (WHO) Guidelines entitled 'Guidance on implementing patient

PHARMANUTRA S.P.A.: AGREEMENT WITH AN INTERNATIONAL ADVISOR IN ORDER TO DEFINE A DEVELOPMENT PLAN FOR PHARMANUTRA USA

Wed, 30 Oct 2024 09:00:00 -0400

PharmaNutra Group is designing a development plan for its US subsidiary with the assistance of a leading international strategic consulting firm

PISA, Italy, Oct. 30, 2024 /PRNewswire/ -- PharmaNutra S.p.A. (MTA; Ticker PHN), specializing in mineral-based nutritional supplements and medical devices for muscles and joints, has signed an agreement with a prominent strategy consulting firm to define the development plan for PharmaNutra USA Corp., its American subsidiary based in Florida, active in the distribution and marketing of the Group's products in the United States.

PHARMANUTRA S.P.A.: AGREEMENT WITH AN INTERNATIONAL ADVISOR IN ORDER TO DEFINE A DEVELOPMENT PLAN FOR PHARMANUTRA USA

Wed, 30 Oct 2024 09:00:00 -0400

PharmaNutra Group is designing a development plan for its US subsidiary with the assistance of a leading international strategic consulting firm

PISA, Italy, Oct. 30, 2024 /PRNewswire/ -- PharmaNutra S.p.A. (MTA; Ticker PHN), specializing in mineral-based nutritional supplements and medical devices for muscles and joints, has signed an agreement with a prominent strategy consulting firm to define the development plan for PharmaNutra USA Corp., its American subsidiary based in Florida, active in the distribution and marketing of the Group's products in the United States.

PHARMANUTRA S.P.A.: AGREEMENT WITH AN INTERNATIONAL ADVISOR IN ORDER TO DEFINE A DEVELOPMENT PLAN FOR PHARMANUTRA USA

Wed, 30 Oct 2024 09:00:00 -0400

PharmaNutra Group is designing a development plan for its US subsidiary with the assistance of a leading international strategic consulting firm

PISA, Italy, Oct. 30, 2024 /PRNewswire/ -- PharmaNutra S.p.A. (MTA; Ticker PHN), specializing in mineral-based nutritional supplements and medical devices for muscles and joints, has signed an agreement with a prominent strategy consulting firm to define the development plan for PharmaNutra USA Corp., its American subsidiary based in Florida, active in the distribution and marketing of the Group's products in the United States.

PHARMANUTRA S.P.A.: AGREEMENT WITH AN INTERNATIONAL ADVISOR IN ORDER TO DEFINE A DEVELOPMENT PLAN FOR PHARMANUTRA USA

Wed, 30 Oct 2024 09:00:00 -0400

PharmaNutra Group is designing a development plan for its US subsidiary with the assistance of a leading international strategic consulting firm

PISA, Italy, Oct. 30, 2024 /PRNewswire/ -- PharmaNutra S.p.A. (MTA; Ticker PHN), specializing in mineral-based nutritional supplements and medical devices for muscles and joints, has signed an agreement with a prominent strategy consulting firm to define the development plan for PharmaNutra USA Corp., its American subsidiary based in Florida, active in the distribution and marketing of the Group's products in the United States.

PHARMANUTRA S.P.A.: AGREEMENT WITH AN INTERNATIONAL ADVISOR IN ORDER TO DEFINE A DEVELOPMENT PLAN FOR PHARMANUTRA USA

Wed, 30 Oct 2024 09:00:00 -0400

PharmaNutra Group is designing a development plan for its US subsidiary with the assistance of a leading international strategic consulting firm

PISA, Italy, Oct. 30, 2024 /PRNewswire/ -- PharmaNutra S.p.A. (MTA; Ticker PHN), specializing in mineral-based nutritional supplements and medical devices for muscles and joints, has signed an agreement with a prominent strategy consulting firm to define the development plan for PharmaNutra USA Corp., its American subsidiary based in Florida, active in the distribution and marketing of the Group's products in the United States.

PHARMANUTRA S.P.A.: AGREEMENT WITH AN INTERNATIONAL ADVISOR IN ORDER TO DEFINE A DEVELOPMENT PLAN FOR PHARMANUTRA USA

Wed, 30 Oct 2024 09:00:00 -0400

PharmaNutra Group is designing a development plan for its US subsidiary with the assistance of a leading international strategic consulting firm

PISA, Italy, Oct. 30, 2024 /PRNewswire/ -- PharmaNutra S.p.A. (MTA; Ticker PHN), specializing in mineral-based nutritional supplements and medical devices for muscles and joints, has signed an agreement with a prominent strategy consulting firm to define the development plan for PharmaNutra USA Corp., its American subsidiary based in Florida, active in the distribution and marketing of the Group's products in the United States.

PHARMANUTRA S.P.A.: THE DISTRIBUTION OF IRON-BASED DIETARY SUPPLEMENTS KICKS OFF IN MEXICO

Thu, 27 Jun 2024 04:00:00 -0400

Partner SMS Pharma will market the three products in the SiderAL^® line under the trade name Sucrosom^®, which is based on our ground-breaking, patented Sucrosomial^® Technology.

PISA, Italy, June 27, 2024 /PRNewswire/ -- This is a new step forward in the steady expansion into foreign markets of PharmaNutra S.p.A. (MTA; Ticker PHN), the company established in 2003 by brothers Andrea and Roberto Lacorte, specializing in medical devices for muscles and joints and mineral-based dietary supplements.

PHARMANUTRA S.P.A.: THE DISTRIBUTION OF IRON-BASED DIETARY SUPPLEMENTS KICKS OFF IN MEXICO

Thu, 27 Jun 2024 04:00:00 -0400

Partner SMS Pharma will market the three products in the SiderAL^® line under the trade name Sucrosom^®, which is based on our ground-breaking, patented Sucrosomial^® Technology.

PISA, Italy, June 27, 2024 /PRNewswire/ -- This is a new step forward in the steady expansion into foreign markets of PharmaNutra S.p.A. (MTA; Ticker PHN), the company established in 2003 by brothers Andrea and Roberto Lacorte, specializing in medical devices for muscles and joints and mineral-based dietary supplements.

PHARMANUTRA S.P.A.: THE DISTRIBUTION OF IRON-BASED DIETARY SUPPLEMENTS KICKS OFF IN MEXICO

Thu, 27 Jun 2024 04:00:00 -0400

Partner SMS Pharma will market the three products in the SiderAL^® line under the trade name Sucrosom^®, which is based on our ground-breaking, patented Sucrosomial^® Technology.

PISA, Italy, June 27, 2024 /PRNewswire/ -- This is a new step forward in the steady expansion into foreign markets of PharmaNutra S.p.A. (MTA; Ticker PHN), the company established in 2003 by brothers Andrea and Roberto Lacorte, specializing in medical devices for muscles and joints and mineral-based dietary supplements.

PHARMANUTRA S.P.A.: THE DISTRIBUTION OF IRON-BASED DIETARY SUPPLEMENTS KICKS OFF IN MEXICO

Thu, 27 Jun 2024 04:00:00 -0400

Partner SMS Pharma will market the three products in the SiderAL^® line under the trade name Sucrosom^®, which is based on our ground-breaking, patented Sucrosomial^® Technology.

PISA, Italy, June 27, 2024 /PRNewswire/ -- This is a new step forward in the steady expansion into foreign markets of PharmaNutra S.p.A. (MTA; Ticker PHN), the company established in 2003 by brothers Andrea and Roberto Lacorte, specializing in medical devices for muscles and joints and mineral-based dietary supplements.

PHARMANUTRA S.P.A.: THE DISTRIBUTION OF IRON-BASED DIETARY SUPPLEMENTS KICKS OFF IN MEXICO

Thu, 27 Jun 2024 04:00:00 -0400

Partner SMS Pharma will market the three products in the SiderAL^® line under the trade name Sucrosom^®, which is based on our ground-breaking, patented Sucrosomial^® Technology.

PISA, Italy, June 27, 2024 /PRNewswire/ -- This is a new step forward in the steady expansion into foreign markets of PharmaNutra S.p.A. (MTA; Ticker PHN), the company established in 2003 by brothers Andrea and Roberto Lacorte, specializing in medical devices for muscles and joints and mineral-based dietary supplements.

PHARMANUTRA S.P.A.: THE DISTRIBUTION OF IRON-BASED DIETARY SUPPLEMENTS KICKS OFF IN MEXICO

Thu, 27 Jun 2024 04:00:00 -0400

Partner SMS Pharma will market the three products in the SiderAL^® line under the trade name Sucrosom^®, which is based on our ground-breaking, patented Sucrosomial^® Technology.

PISA, Italy, June 27, 2024 /PRNewswire/ -- This is a new step forward in the steady expansion into foreign markets of PharmaNutra S.p.A. (MTA; Ticker PHN), the company established in 2003 by brothers Andrea and Roberto Lacorte, specializing in medical devices for muscles and joints and mineral-based dietary supplements.

PHARMANUTRA S.P.A.: THE DISTRIBUTION OF IRON-BASED DIETARY SUPPLEMENTS KICKS OFF IN MEXICO

Thu, 27 Jun 2024 04:00:00 -0400

Partner SMS Pharma will market the three products in the SiderAL^® line under the trade name Sucrosom^®, which is based on our ground-breaking, patented Sucrosomial^® Technology.

PISA, Italy, June 27, 2024 /PRNewswire/ -- This is a new step forward in the steady expansion into foreign markets of PharmaNutra S.p.A. (MTA; Ticker PHN), the company established in 2003 by brothers Andrea and Roberto Lacorte, specializing in medical devices for muscles and joints and mineral-based dietary supplements.

PHARMANUTRA S.P.A.: THE DISTRIBUTION OF IRON-BASED DIETARY SUPPLEMENTS KICKS OFF IN MEXICO

Thu, 27 Jun 2024 04:00:00 -0400

Partner SMS Pharma will market the three products in the SiderAL^® line under the trade name Sucrosom^®, which is based on our ground-breaking, patented Sucrosomial^® Technology.

PISA, Italy, June 27, 2024 /PRNewswire/ -- This is a new step forward in the steady expansion into foreign markets of PharmaNutra S.p.A. (MTA; Ticker PHN), the company established in 2003 by brothers Andrea and Roberto Lacorte, specializing in medical devices for muscles and joints and mineral-based dietary supplements.

PHARMANUTRA S.P.A.: THE DISTRIBUTION OF IRON-BASED DIETARY SUPPLEMENTS KICKS OFF IN MEXICO

Thu, 27 Jun 2024 04:00:00 -0400

Partner SMS Pharma will market the three products in the SiderAL^® line under the trade name Sucrosom^®, which is based on our ground-breaking, patented Sucrosomial^® Technology.

PISA, Italy, June 27, 2024 /PRNewswire/ -- This is a new step forward in the steady expansion into foreign markets of PharmaNutra S.p.A. (MTA; Ticker PHN), the company established in 2003 by brothers Andrea and Roberto Lacorte, specializing in medical devices for muscles and joints and mineral-based dietary supplements.